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Abstract  A  64-year-old  man  with  a  renal  cell  carcinoma  (RCC)  underwent  right  nephrectomy.
There was  no  identiﬁable  recurrence  during  follow-up.  Six  years  after  surgery  he  presented
with melena  and  ferropenic  anaemia.  Endoscopic  evaluation  demonstrated  a  vascular  lesion
in duodenum  and  haemostasis  was  performed.  However,  the  bleeding  recurred  and  further
endoscopies  revealed  an  enlarged  multilobulated  inﬁltrative  and  ulcerative  lesion  over  the
duodenum  bulb.  Histological  and  imagiological  investigations  were,  even  so,  suggestive  of  a
vascular lesion  adjacent  to  the  duodenal  wall.  Given  the  uncertain  diagnosis  and  recurrent
bleeding a  surgical  resection  was  deemed  unavoidable.  A  cephalic  duodenopancreatectomy  was
performed  and  histologic  evaluation  revealed  an  intrapancreatic  RCC  metastasis  with  duodenal
inﬁltration.  No  evidence  of  recurrence  after  12  months  was  observed.
In conclusion,  RCC  metastasis  should  be  considered  in  patients  with  a  pancreatic  mass  as  it
gives the  past  history  of  RCC.  Awareness  of  this  entity  and  a  high  index  of  suspicion  would  help
in proper  diagnosis  and  treatment.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
PALAVRAS-CHAVE
Carcinoma  de  células
Metástase  intrapancreática  de  tumor  de  células  renais:  causa  rara  de  hemorragia
digestiva  alta  recorrenterenais  Metástase
intrapancreática
Hemorragia  duodenal
Resumo  Doente  do  sexo  masculino  de  64  anos  de  idade,  submetido  a  nefrectomia  direita  há
6 anos,  sem  recidiva  identiﬁcável  durante  o  follow-up,  apresentou-se  com  melena  e  anemia
ferropriva.  A  avaliac¸ão  endoscópica  mostrou  lesão  vascular  no  duodeno  tendo  sido  submetido  a
hemóstase com  sucesso.  No  entanto,  após  3  meses,  ocorreu  recidiva  hemorrágica,  observando-
se lesão  inﬁltrativa  e  ulcerada  multilobulada  no  bulbo  duodenal.  O  estudo  histológico
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e  imagiológico  eram  sugestivos  de  uma  lesão  vascular  adjacente  à  parede  do  duodenal.  Dado  o
diagnóstico incerto  e  hemorragia  recorrente,  optou-se  por  realizac¸ão  de  ressecc¸ão  cirúrgica.  A
gastroduodenopancreatectomia  cefálica  revelou  a  presenc¸a  de  metástase  de  carcinoma  de  célu-
las renais  intrapancreática  com  inﬁltrac¸ão  duodenal.  Não  foi  observada  evidência  de  recidiva
após 12  meses.
Em  conclusão,  as  metástases  do  carcinoma  de  células  renais  devem  ser  consideradas  em
pacientes  com  massa  pancreática  e  história  de  RCC.  A  consciência  desta  entidade  e  um  alto
índice de  suspeita  é  necessário  para  o  diagnóstico  e  tratamento  adequado.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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Renal  cell  carcinoma  (RCC)  has  the  potential  to  metastasize
to  almost  any  site.  Metastatic  disease  may  be  present  in  up
to  25%  of  patients  at  the  time  of  diagnosis  while  another
50%  develop  metastasis  during  follow-up.1,2 Its  tendency  to
vascular  spreading  as  well  as  expansible  ostetolytic  skeletal
metastization  is  well  known.  However,  it  is  less  expected
that  RCC  presents  as  an  unpredictable  tumour  which  can
manifest  with  very  late  metastases  at  unexpected  sites,
even  a  long  period  after  successful  resection  of  early  stage
lesion.3,4 Common  metastatic  sites  for  RCC  are  lungs,  bone,
liver,  adrenal  glands  and  brain,  being  rarely  detected  in  thy-
roid  gland,  gallbladder,  pancreas  and  orbit.5
In  this  paper,  we  report  a  case  of  a  64-years-old  man
with  solitary  pancreatic  metastasis  with  duodenal  inﬁltra-
tion  manifested  as  recurrent  upper  gastrointestinal  bleeding
6  years  after  nephrectomy.
Case report
A  64-year-old  man  presented  in  the  emergency  room  with
melena.  He  also  referred  fatigue  and  generalized  weakness
for  the  previous  3  days.  He  had  no  associated  symptoms
and  denied  hematemesis,  fresh  rectal  bleeding,  abdominal
pain  or  weight  loss.  There  was  no  history  of  recent  use  of
non-steroidal,  anti-inﬂammatory,  anticoagulant  and  antia-
gregant  drugs.  His  past  medical  history  was  signiﬁcant  for
hypertension  and  radical  right  nephrectomy,  6  years  before,
for  pseudocapsulated  renal  cell  carcinoma  involving  the  cen-
tral  part  of  the  kidney.  Microscopically,  the  tumour  was
classiﬁed  as  clear-cell  with  eosinophilic  and  granular  cells,
grade  II/III  in  the  Furhman’s  nuclear  grading  system,  with
no  calyx,  capsular  or  vascular  involvement  and  the  ureter
and  hilar  lymph  nodes  were  also  free  of  tumour.  Abdomi-
nal  contrast  enhanced  computed  tomography  (CT)  revealed
no  metastization  and  the  patient  was  staged  as  T1N0M0.
No  adjuvant  chemotherapy  was  administered  in  view  of  a
favourable  tumour  histopathology.  He  was  placed  on  regular
oncology  follow-up  and  had  been  disease  free  up  to  his  last
visit.
On  clinical  examination  he  was  hemodynamically  stable
and  appeared  pale.  Abdominal  examination  was  unremark-
able  (except  for  a  surgical  scar  of  right  nephrectomy).
(
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naboratory  investigation  on  admission  was  signiﬁcant  for
ormocytic  anaemia  with  haemoglobin  8.1  g/dl  and  leuco-
ytosis  (14.6  ×  109/l).  The  upper  gastrointestinal  endoscopy
UGIE)  showed  an  oozing  haemorrhage  from  a  solitary  vas-
ular  lesion,  without  ulceration,  in  the  duodenum  bulb.  It
as  injected  with  diluted  (1:10,000)  epinephrine  and  three
ndoclips  (EZ  clip,  HX-610-090  l,  Olympus,  Pennsylvania,
UA)  were  applied,  with  proper  haemostasis  at  the  end  of
he  procedure.  After  endoscopic  review  he  was  discharged
n  day  4,  with  proton-pump  inhibitor  (pantoprazole  40  mg
d).  As  an  outcome  patient,  he  did  the  Helicobacter  pylori
rea  breath  test,  which  was  negative.
Three  months  later,  the  patient  suffered  from  another
pisode  of  melena,  without  haemodynamic  repercussion,
ut  with  mild  anaemia  (10.5  g/dl).  Upper  GI  endoscopy
evealed  an  active  oozing  bleeding  originating  from  an
rregular,  polypoid,  eroded  mass  (1  cm)  in  the  ﬁrst  portion
f  the  duodenum  (Fig.  1a).  The  lesion  showed  violet  promi-
ent  structures,  consistent  with  vascular  nature.  We  chose
o  inject  n-butyl-2-cyanoacrylate  glue  (Histoacryl®) and
ipiodol® (0.5  ml  +  0.5  ml)  in  the  central  region  of  the  lesion,
ith  haemostatic  success  (Fig.  1b).  The  patient  was  dis-
harged  on  the  5th  day  of  hospitalization  after  endoscopic
evision,  which  identiﬁed  different  characteristics  of  the
esion,  that  was  now  very  irregular,  with  central  ulcer-
ted  pigmented  prominences  (Fig.  2a).  Biopsies  were  taken
nd  histological  examination  revealed  morphological  ﬁnd-
ngs  compatible  with  an  angiomatous  lesion.
He  was  referred  for  detailed  imaging  and  labora-
ory  investigation,  including  abdominal  angio-computerized
omography  (CT)  and  endoscopic  ultrasonography  (EUS).  The
T  scan  revealed  a  lesion  between  the  pancreas  and  the
uodenum  with  42  mm  ×  30  mm,  but  ill  deﬁned,  with  no
bvious  mass  effect,  with  multiple  millimetric  calciﬁcations.
his  lesion  was  associated  with  slight  regular  thickening
f  the  wall  of  the  duodenal  bulb,  which  could  correspond
o  angiomatous  lesion  (Fig.  3a  and  b).  No  other  alter-
tions  were  identiﬁed,  including  tumour  recurrence  at  the
ephrectomy  site.  In  the  duodenal  bulb,  EUS  revealed  a
ultilobulated  ulcerated  lesion,  occupying  two  thirds  of
he  circumference,  violaceous,  easily  bleeding  on  contact
Fig.  2b),  which  was  reﬂected  in  ultrasound  as  heteroge-
eous  wall  thickness  (12  mm).  Hemogram  (including  MCV)
nd  biochemical  tumour  markers  (CEA  and  CA  19.9)  were
ormal.
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Figure  1  Irregular,  polypoid,  eroded  mass  (1  cm)  in  the  ﬁrst  portion  of  the  duodenum,  with  active  oozing  bleeding,  before  (a)  and
after (b)  n-butyl-2-cyanoacrylate  glue  (Histoacryl®)  and  Lipiodol® injection.
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aigure  2  (a)  Irregular  duodenal  lesion,  with  central  ulcera
ccupying two  thirds  of  the  circumference,  violaceous,  easily  b
After  the  third  upper  gastrointestinal  bleeding  (with
isualization  of  a  multilobulated,  ulcerated  and  viola-
eous  bleeding  lesion  on  the  duodenum)  and  based  on
linical  history,  the  patient  underwent  elective  laparo-
omy.  Intraoperatively,  a  4  cm  lesion  was  identiﬁed  in  the
ancreatic  head  with  inﬁltration  of  the  duodenum  wall
nd  endoluminal  growth,  which  was  resected  by  classic
ancreaticoduodenectomy  --  Whipple’s  procedure  (Fig.  4).
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igure  3  CT  images  of  the  lesion  between  the  pancreas  and  the  d
ssociated with  slight  regular  thickening  of  the  wall  of  the  duodenapigmented  prominences.  (b)  Multilobulated  ulcerated  lesion,
ing  on  contact.
istology  and  immunohistochemistry  studies  revealed  an
ntrapancreatic  metastasis  from  renal  cell  carcinoma,  with
uodenal  wall  inﬁltration,  surrounded  by  a  ﬁbrous  pseudo-
apsule  (Fig.  5a  and  b).  The  surgical  margins  were  free  of
umour  and  no  metastases  were  found  in  the  regional  lymph
odes.
The  follow-up  was  uneventful  with  no  evidence  of  recur-
ence  at  12  months.
uodenum,  ill-deﬁned,  with  multiple  millimetric  calciﬁcations,
l  bulb  --  (a)  axial  and  (b)  coronal.
Pancreatic  metastasis  from  renal  cell  carcinoma  
R
t
h
c
b
d
i
m
u
t
u
w
T
u
t
m
s
a
r
ﬁ
c
s
a
A
o
c
f
8
p
w
l
a
m
s
a
f
t
poorer  when  the  metachronous  metastasis  develop  beforeFigure  4  Surgical  specimen  with  an  intrapancreatic  mass.
Discussion
Pancreatic  metastasis  is  a  rarity  and  seen  in  only  3--12%  of
patients  with  disseminated  malignancy  at  autopsy.  Major-
ity  forms  are  metastasis  from  primary  sites  such  as  lungs,
breast,  renal  cell  carcinoma,  colon  and  melanoma.6 The
incidence  of  metastasis  from  primary  renal  cell  carcinoma
to  pancreas  ranges  from  0.5  to  3%  of  all  metastatic  RCC.7--9
However,  when  these  rarities  converge,  it  forms  a  unique
association  in  which  RCC  is  the  most  common  primary
tumour  in  30%  of  all  patients  with  pancreatic  metastasis.6,10
These  are  usually  detected  many  years  after  nephrectomy,
ranging  from  6  to  8  years.10--12 The  metastization  from  RCC
to  pancreas  may  occur  by  haematogenous  or  lymphatic
dissemination,  the  direct  spread  to  the  pancreas  being
unusual.13 In  2006,  Sellner  et  al.14 identiﬁed  236  cases  of
isolated  pancreatic  metastasis  of  RCC,  either  asymptomatic
in  35%  of  the  cases,  or  presenting  with  abdominal  pain
(20%),  GI  bleeding  (20%),  obstructive  jaundice  (9%),  weight
loss  (9%),  pancreatitis  and  diabetes  (3%  each).  Symptoms
were  tumour  diameter-dependent,  more  frequent  in  those
9with  more  than  45  mm. In  the  case  presented,  imagiolog-
ical  evaluation  demonstrated  a  typical  well  deﬁned  lesion,
with  characteristic  hypervascularity  manifested  by  contrast
enhancement,  that  is  usually  seen  in  over  75%  patients.3,11
o
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Figure  5  (a)  Intrapancreatic  metastasis  from  renal  cell  carcino
pseudocapsule;  H&E  20×.  (b)  Intrapancreatic  metastasis  from  renal  83
It  is  also  difﬁcult  to  diagnose  primary  or  metastatic
CC  in  small  biopsies  because  of  the  wide  variety  of  his-
ologic  appearance,15 which  may  explain  why  there  was  no
istologic  conﬁrmation  and  deﬁnitive  diagnosis  until  surgi-
al  exploration.  The  natural  history  of  duodenal  ulcers  is
enign,  and  there  is  no  association  with  carcinoma.16 It  is
ifﬁcult  to  differentiate  malignant  from  benign  ulcers  in
nitial  endoscopic  evaluation.  However,  the  possibility  of
alignancy  of  the  duodenal  ulcer  should  be  considered  if  the
lcer  does  not  heal  after  8 weeks  of  medical  treatment  or  if
here  are  polypoid  or  submucosal  masses  with  elevation  and
lceration  at  the  apex  or  multiple  nodules  of  varying  sizes
ith  tip  ulceration  on  repeated  endoscopic  examination.
his  kind  of  lesion  may  need  aggressive  biopsy  techniques
sing  Jumbo  forceps  or  surgical  biopsy  to  obtain  sufﬁcient
issue  for  diagnosis.17
Surgical  resection  of  primary  renal  cell  carcinoma  and
etastatic  deposits  remains  the  most  effective  treatment
ince  chemotherapy,  radiotherapy  and  hormonal  ther-
py  have  proven  ineffective.7,10 A  metachronous  solitary
esectable  metastasis  of  an  RCC  or  multiple  metastasis  con-
ned  to  one  organ  (like  pancreas)  are  suitable  surgical
andidates.7,18 Surgical  procedures  vary  according  to  the
ite  and  the  extent  of  the  lesion,  including  distal  pancre-
tectomy,  pancreatoduodenectomy  or  tumour  enucleation.
 relatively  good  prognosis  has  been  observed  in  the  absence
f  lymphatic  spread  and  in  local  recurrence.7,9 The  out-
ome  of  isolated  pancreatic  RCC  metastasis  is  clearly  more
avourable  with  a  mean  5  years  survival  ranging  from  43  to
8%,  even  better  than  that  of  primary  adenocarcinoma  of
ancreas.7,8 In  a  systematic  review  of  more  than  400  patients
ith  RCC  pancreatic  metastasis,  Tanis  et  al.18 found  that
ong  disease-free  interval  (preferably  more  than  2  years)
fter  resection  of  primary  tumour,  a  single,  asymptomatic
etastatic  deposit  with  central  necrosis  and  complete  exci-
ion  of  the  secondary  lesion  (with  negative  margins)  are
ssociated  with  good  prognosis.  In  addition,  other  authors
ound  that  synchronous  had  worse  prognosis  when  compared
o  metachronous  solitary  metastasis.19 The  prognosis  is  alsone  year  after  nephrectomy.20 Recently,  immunotherapy
as  shown  encouraging  results  in  advanced  RCC  (e.g.  Beva-
izumab,  Sunitinib,  and  Sorafenib).  It  has  been  used  in  cases
ma,  with  duodenal  wall  inﬁltration,  surrounded  by  a  ﬁbrous
cell  carcinoma,  with  duodenal  wall  inﬁltration;  H&E  400×.
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14  
ith  aggressive  growth  pattern,  extrarenal  disease  at  explo-
ation  or  as  neoadjuvant  therapy  in  locally  unresectable
isease.18 Though  in  isolated  lesions,  liable  to  excision,
urgery  is  still  the  ﬁrst  line  therapy.
We  report  this  case  to  highlight  the  importance  of  inves-
igating  patients  with  history  of  RCC  presenting  with  any
astro-intestinal  tract  manifestations  looking  for  metasta-
is.  In  our  patient,  three  episodes  of  GI  bleeding  from  an
ntrapancreatic  metastasis  presented  after  a  long  disease-
ree  interval  of  6  years.  The  two  endoscopies  performed  in
he  context  of  the  two  episodes  of  upper  gastrointestinal
leeding  described  in  the  case  report  were  considered  rela-
ively  innocent.  The  ﬁrst  episode  was  described  as  probable
imple  duodenal  vascular  injury  -- duodenal  Dieulafoy.  The
econd  episode,  despite  identiﬁcation  of  a  polypoid  eroded
tructure,  the  endoscopic  appearance  (conﬁrmed  by  histol-
gy)  suggested  a  vascular  lesion  (angiomatous  structure).
owever,  endoscopic  revision  evidenced  a  sudden  and  sig-
iﬁcant  change  in  the  lesion  characteristics  and  growth.  It
as  then  described  as  an  inﬁltrating  and  ulcerated  mass.
T  did  not  allow  a  precise  etiological  characterization  of
he  lesion.  Unfortunately,  the  radial  EUS  was  suboptimal  in
erms  of  quality  due  to  technical  constraints,  limiting  the
dentiﬁcation  of  lesions  to  the  most  superﬁcial  layers  of  the
all,  which  was  not  coincident  with  the  CT  images.  Surgical
ecision  was  based  not  only  on  the  endoscopic  appearance  of
he  lesion  and  risk  of  bleeding,  but  also  taking  into  account
he  neoplastic  background.  We  opted  not  to  perform  EUS-
NA  before  surgery  because  negative  results  do  not  change
he  previously  established  surgical  strategy  due  to  low  sen-
itivity  of  this  technique.
In  conclusion,  we  think  that  RCC  metastasis  should
e  considered  if  any  patient  with  a  pancreatic  tumour
ives  past  history  of  surgery  for  RCC.  On  the  other  hand
ost-nephrectomy  patients  with  RCC  suffering  from  gas-
rointestinal  bleeding  must  have  a  complete  evaluation,
specially  endoscopic  examination,  because  late  recurrent
enal  cell  carcinoma  metastasis  to  the  GI  tract  should  be
ept  in  mind,  although  rare.  Awareness  of  this  entity  and
 high  index  of  suspicion  by  the  physician  and  pathologist
ould  help  in  proper  diagnosis  and  treatment.
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